Inna Kalickman
- Co-authors
- Vivian BarakJacob Pe’erShahar FrenkelBenjamin NismanShlomo BirkenfeldYehuda ShoenfeldAndrew J. ManiotisRobert Folberg
- Topics
- Ocular Oncology and Treatments (4 papers)Cancer Research and Treatments (3 papers)Corneal Surgery and Treatments (2 papers)
- Cited by
- OphthalmologyNephrologyImmunology
- Journals
- The American Journal of MedicineFertility and SterilityInvestigative Ophthalmology & Visual Science
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Inna Kalickman
11 papers receiving 485 citations
Peers
Comparison fields: 5 of 83
- Molecular Biology 160
- Ophthalmology 146
- Immunology 111
- Pulmonary and Respiratory Medicine 87
- Oncology 83
Countries citing papers authored by Inna Kalickman
This map shows the geographic impact of Inna Kalickman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inna Kalickman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inna Kalickman more than expected).
Fields of papers citing papers by Inna Kalickman
This network shows the impact of papers produced by Inna Kalickman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inna Kalickman. The network helps show where Inna Kalickman may publish in the future.
Co-authorship network of co-authors of Inna Kalickman
This figure shows the co-authorship network connecting the top 25 collaborators of Inna Kalickman. A scholar is included among the top collaborators of Inna Kalickman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inna Kalickman. Inna Kalickman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 48 | |
| 2 | Trends in liver function tests: a comparison with serum tumor markers in metastatic uveal melanoma (part 2). | 18 |
| 3 | The dynamics of serum tumor markers in predicting metastatic uveal melanoma (part 1). | 26 |
| 4 | Serum markers to detect metastatic uveal melanoma. | 60 |
| 5 | 11 | |
| 6 | 59 | |
| 7 | PADMA-28, a Tibetan herbal preparation is an inhibitor of inflammatory cytokine production. | 28 |
| 8 | 23 | |
| 9 | The effect of herbal remedies on the production of human inflammatory and anti-inflammatory cytokines. | 75 |
| 10 | 30 | |
| 11 | 136 |
About Inna Kalickman
Inna Kalickman is a scholar working on Ophthalmology, Biotechnology and Complementary and alternative medicine, having authored 11 papers that have together received 514 indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (4 papers), Cancer Research and Treatments (3 papers) and Corneal Surgery and Treatments (2 papers). The work is most often cited by research in Ophthalmology (146 citations), Nephrology (67 citations) and Immunology (111 citations). Inna Kalickman has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Vivian Barak, Jacob Pe’er, Shahar Frenkel, Benjamin Nisman, Shlomo Birkenfeld, Yehuda Shoenfeld, Andrew J. Maniotis, Robert Folberg, Igor Kaiserman and Isaac Ginsburg. Their work appears in journals such as The American Journal of Medicine, Fertility and Sterility and Investigative Ophthalmology & Visual Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.